Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

Clinical trial NCT00211198 · COMPLETED

Trial details

NCT number: NCT00211198
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous

Start date: 2001-05-01
Primary completion: 2005-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.